Genmab A/S (GMAB)
44.12
+0.34
(+0.77%)
USD |
NASDAQ |
Oct 26, 13:11
Genmab Price : 44.12 for Oct. 26, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 39.84 | 44.34 | 39.64 | 43.79 | 13.00M |
| Oct 22, 2026 | 39.68 | 40.16 | 39.50 | 40.00 | 4.686M |
| Oct 21, 2026 | 39.08 | 39.66 | 39.05 | 39.57 | 2.973M |
| Oct 20, 2026 | 38.60 | 39.40 | 38.42 | 39.07 | 3.780M |
| Oct 19, 2026 | 37.89 | 39.00 | 37.76 | 38.50 | 4.776M |
| Oct 16, 2026 | 38.14 | 38.20 | 36.74 | 37.00 | 2.685M |
| Oct 15, 2026 | 37.20 | 38.33 | 37.04 | 37.82 | 4.084M |
| Oct 14, 2026 | 36.38 | 37.24 | 36.12 | 36.89 | 2.687M |
| Oct 13, 2026 | 37.23 | 37.35 | 36.34 | 36.57 | 3.737M |
| Oct 12, 2026 | 37.18 | 37.71 | 36.94 | 37.37 | 3.128M |
| Oct 09, 2026 | 36.55 | 37.15 | 36.33 | 37.07 | 2.334M |
| Oct 08, 2026 | 36.18 | 36.28 | 35.09 | 36.05 | 4.300M |
| Oct 07, 2026 | 37.28 | 37.87 | 36.27 | 36.65 | 4.254M |
| Oct 06, 2026 | 39.11 | 39.15 | 37.07 | 37.80 | 6.596M |
| Oct 05, 2026 | 35.09 | 40.17 | 35.02 | 38.48 | 12.40M |
| Oct 02, 2026 | 34.39 | 35.02 | 33.72 | 34.75 | 5.436M |
| Oct 01, 2026 | 35.25 | 35.80 | 34.52 | 34.55 | 6.377M |
| Sep 30, 2026 | 35.72 | 35.90 | 35.37 | 35.68 | 5.155M |
| Sep 29, 2026 | 34.94 | 35.64 | 34.89 | 35.57 | 3.828M |
| Sep 28, 2026 | 34.76 | 35.70 | 34.63 | 35.36 | 2.795M |
| Sep 25, 2026 | 34.95 | 35.47 | 34.70 | 35.32 | 3.583M |
| Sep 24, 2026 | 34.69 | 35.03 | 34.36 | 34.83 | 2.515M |
| Sep 23, 2026 | 35.39 | 35.66 | 34.60 | 34.75 | 2.510M |
| Sep 22, 2026 | 34.46 | 35.30 | 34.37 | 35.22 | 2.298M |
| Sep 21, 2026 | 34.70 | 34.86 | 34.36 | 34.69 | 1.577M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 285.74 |
| Ascendis Pharma A/S | 245.05 |
| Zealand Pharma A/S | 33.88 |
| Bavarian Nordic A/S | 12.28 |
| Evaxion AS | 3.02 |
Price Related Metrics
| PE Ratio | 34.94 |
| PS Ratio | 6.813 |
| Price to Book Value | 4.422 |
| Price to Free Cash Flow | 32.36 |
| Earnings Yield | 2.86% |
| Market Cap | 26.34B |
| Operating PE Ratio | 21.11 |
| Normalized PE Ratio | 28.64 |